Report ID: SQMIG35A3050
Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Medical Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Medical Devices industry players.
The global medical devices market is greatly impacted by an older population, as older individuals are more likely to develop chronic and degenerative disease states such as cardiovascular disease, arthritis, diabetes, and neurological disease. Due to the greater incidence of multiple medical conditions, there is greater overall demand for diagnostic equipment, imaging devices, implants, and treatments to deal with the complexities of these medical conditions faced by older patients. In response, healthcare providers are making capital expenditures on medical devices that will facilitate disease management, early detection, and ultimately address population needs for better clinical outcomes. Consequently, the increasing proportion of elderly patients directly contributes to sustained market growth and innovation in medical device development.
According to SkyQuest Technology Medical Devices Market is projected to grow at a CAGR of over 5.6% by 2032, on account of urgent need for automating quantified data. Technological advancements serve as a crucial factor shaping the medical devices market. Innovations such as minimally invasive surgical tools, robotic-assisted devices, wearable health monitors, and AI-powered diagnostic systems have transformed healthcare delivery.
|
Company |
Est. Year |
Headquarters |
Revenue |
Key Services |
|
Medtronic |
1949 |
Minneapolis, Minnesota |
$32.36 Billion (2024) |
Cardiac devices, insulin pumps, neurological devices, spinal and orthopaedic devices, surgical instruments, patient monitoring systems |
|
Johnson & Johnson MedTech |
1886 |
New Brunswick, New Jersey |
$46.25 Billion (2023) |
Surgical instruments, orthopaedics, cardiovascular devices, vision care products, diagnostic equipment, infection prevention solutions |
|
Siemens Healthineers |
1847 |
Erlangen, Bavaria |
$24 Billion (2024) |
Diagnostic imaging, laboratory diagnostics, point-of-care testing, molecular diagnostics, advanced therapies, digital health solutions |
|
GE HealthCare |
1892 |
Chicago, Illinois |
$19.67 Billion (2024) |
Medical imaging equipment, ultrasound systems, patient monitoring, anaesthesia delivery, life sciences equipment, digital healthcare solutions |
|
Philips Healthcare |
1891 |
Amsterdam, Netherlands |
$19.37 Billion (2024) |
Diagnostic imaging, patient monitoring, healthcare informatics, sleep and respiratory care, image-guided therapy, connected care solutions |
|
Abbott Laboratories |
1888 |
Abbott Park, Illinois |
$42 Billion (2024) |
Cardiovascular devices, diabetes care products, diagnostics, nutrition products, molecular diagnostics, point-of-care testing |
|
Stryker Corporation |
1941 |
Kalamazoo, Michigan |
$19.61 Billion (2024) |
Orthopaedic implants, surgical equipment, neurotechnology, spine devices, endoscopy systems, emergency medical equipment |
|
Boston Scientific |
1979 |
Marlborough, Massachusetts |
$16.747 Billion (2024) |
Cardiac rhythm management, interventional cardiology, endoscopy, urology, peripheral interventions, neuromodulation devices |
|
Becton, Dickinson and Company |
1897 |
Franklin Lakes, New Jersey |
$39.11 Billion (2024) |
Medication management, diagnostic systems, biosciences research tools, injection and infusion devices, microbiology, molecular diagnostics |
|
Zimmer Biomet |
1927 |
Warsaw, Indiana |
$7.679 Billion (2024) |
Orthopaedic implants, musculoskeletal reconstructive products, spine and trauma devices, dental implants, surgical instruments, robotics-assisted surgery |
Get access to in-depth company analysis, revenue breakdowns, and market positioning - Request Free Sample Report
Medtronic PLC is an international leader in medical technology, ideas and services with the goal of alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic was established in 1949 and has developed into a multi-billion-dollar organization that operates in more than 150 countries. Medtronic's main offerings include therapies in a wide range of therapeutic areas including pacemakers, surgical robots and diabetes management systems. Recently, Medtronic has made great advancements in its Diabetes portfolio with major FDA and CE Mark approvals for its MiniMed™ 780G system, which integrates with advanced glucose sensors.
Johnson & Johnson MedTech is a worldwide leader specialized in medical devices, surgical solutions and healthcare innovation who is committed to improving patient outcomes and advancing quality of life. Founded in 1886 and based in New Brunswick, New Jersey (USA), we operate across a range of therapeutic areas including orthopaedics, cardiovascular care, surgery and eye health. The large portfolio consists of advanced surgical instruments, joint reconstruction systems, minimally invasive solutions, and diagnostic instruments. Johnson & Johnson MedTech continually invests in R&D with a focus on integration with digital health and robotics-assisted procedures to improve clinical efficiency.
Siemens Healthineers is an international leader in medical technology committed to improving healthcare quality with innovations in diagnostics, imaging, and digital services. Established in 1847, and based in Erlangen, Germany, the company has established its presence in more than 70 countries. Siemens Healthineers' broad portfolio includes diagnostic imaging systems, laboratory diagnostics, molecular testing, and advanced therapies that enable highly accurate and minimally invasive procedural solutions. Siemens Healthineers is also disrupting digital health, using AI and data-driven platforms to improve clinical practitioner decision-making and efficiency. Their recent strategic moves, including the acquisition of Varian Medical Systems, allows for new capabilities in oncology care.
GE HealthCare is a top global supplier of medical technology, diagnostic equipment and digital solutions and is dedicated to empowering the world to achieve better patient outcomes and more precise health. Founded in 1892, with headquarters in Chicago, Illinois, USA, the company works across more than 100 countries. GE HealthCare's product offerings include medical imaging systems, ultrasound, patient monitoring, anesthesia delivery and life sciences, all of which strive to enhance clinical decision-making and improve patient outcomes. GE HealthCare is also a leader in digital health using AI-enabled platforms, connected care and improved analytics to help support efficient workflows.
Philips Healthcare, part of Koninklijke Philips N.V., is a global health technology leader that is passionate about improving lives through meaningful innovation along the health continuum. The company was founded in 1891 and is headquartered in Amsterdam, Netherlands, with operations in over 100 countries. Its portfolio spans diagnostic imaging, image-guided therapy, patient monitoring, and connected care solutions, with a robust offering in sleep and respiratory care as well. Philips Healthcare is widely recognized for unifying various innovations- artificial intelligence, cloud computing, and data analytics- with the goal of improving clinical productivity and patient care.
Abbott Laboratories is a global leader in healthcare with a purpose of advancing the science of medicine in line with safe, effective innovations in diagnostics, devices, nutrition and branded generic medicines. Founded in 1888 and headquartered in Abbott Park, Illinois, USA, Abbott serves patients and their healthcare providers throughout more than 160 countries. Abbott's varied portfolio of medical device products includes cardiovascular technologies, diabetes care solutions such as the FreeStyle Libre continuous glucose monitoring system, and neuromodulation products. Abbott is also a key provider of diagnostics, including systems that can identify disease rapidly and accurately, from molecular testing, point-of-care testing, to laboratory testing products.
Stryker Corporation ranks as a global leader in medical technology, specifically concentrating on creating innovative solutions for patients in the orthopedic, medical and surgical device, and neurotechnology fields. Founded in 1941 and based in Kalamazoo, Michigan, USA, Stryker in also present in over 75 countries. Their product offerings range from joint replacement implants, trauma and spine implants, surgical navigational systems, endoscopy, and emergency medical products such as stretchers and defibrillators. Stryker Corporation is also engaged in robotics-assisted surgery and digital health technology, in order to increase accuracy for better efficiency in operating rooms.
Boston Scientific is an international pioneer in medical technology, focused on utilizing technology to transform lives through innovative Therapeutic solutions in interventional medicine. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts, USA. Boston Scientific operates in more than 100 countries around the world. Boston Scientific's product portfolio conserves cardiovascular care (stents and devices for managing heart rhythms); minimally invasive solutions in urology, endoscopy, neuromodulation and peripheral interventions. Boston Scientific is well known for driving less invasive procedures that lead to quicker recovery and better patient outcomes.
Becton, Dickinson and Company (BD) is one of the global leaders in medical technology to advance healthcare by improving diagnostics, improving drug delivery and enabling safer patient care. It was founded it 1897 and is headquartered in Franklin Lakes, New Jersey, USA, but has operations in over 190 countries. BD offers a comprehensive portfolio of medical supplies, including needles and syringes, infusion therapy systems, advanced diagnostic instruments and biosciences research tools. The company is dedicated to infection prevention, medication management and molecular diagnostics in both clinical and laboratory settings. BD believes that innovation and collaboration are cornerstones in addressing urgent healthcare needs, from prevention of infectious disease to support precision medicine, solidifying BD as one of the global healthcare solutions and better patient safety.
Zimmer Biomet is a major international medical device company that focuses on musculoskeletal health care and is dedicated to restoring mobility and improving the quality of life for patients around the globe. Founded in 1927 and based in Warsaw, Indiana, USA, the company is a recognized leader in more than 100 countries. Its extensive product line consists of orthopedic implants, joint reconstruction systems, dental implants, spine and trauma products, and surgical instruments. Zimmer Biomet is also innovating the next phase of robotics-assisted surgery and digital health platforms to improve accuracy of surgical procedures and improve patient outcomes. Through the integration of innovation, clinical experience, and patient-centered solutions, Zimmer Biomet continues to advance the future of musculoskeletal care and strengthen its position in global medical devices.
The global medical devices market is steadily growing globally, including demography, technology, and healthcare challenges. The aging population causes increased demand for advanced diagnostic, therapeutics, and surgical devices, while innovations in robotics, artificial intelligence, and minimally invasive devices redefine care delivery. Major brands like Medtronic, Johnson & Johnson MedTech, Siemens Healthineers, and others continue investing in research and development, and all things digital to improve health outcomes and efficiencies. Having strong players, a diversified product and service offering, and ongoing developments creates an optimal setting, leading to sustainable growth, enhancement of access to care, and revolutionizing care delivery to more areas around the world.
REQUEST FOR SAMPLE
Global Medical Devices Market size was valued at USD 1136 Billion in 2024 and is poised to grow from USD 1199.62 Billion in 2025 to USD 1855.04 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026–2033).
Medtronic plc, Johnson & Johnson, Abbott Laboratories, Koninklijke Philips N.V. (Philips), F. Hoffmann-La Roche AG, OMRON Corporation, DexCom, Inc., Medline Industries, LP, Stryker Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Withings S.A.S., Beurer GmbH, Nihon Kohden Corporation, Qardio, Inc., ICU Medical, Inc., Terumo Corporation, iHealth Labs Inc., Contec Medical Systems Co., Ltd., A&D Company, Limited
The key driver of the medical devices market is the increasing demand for advanced healthcare solutions, fueled by the rising prevalence of chronic and lifestyle diseases, aging populations, technological innovations, and growing investments in healthcare infrastructure globally.
A key market trend in the medical devices market is the growing adoption of digital health technologies, including wearable devices, remote monitoring, and AI-driven diagnostic tools, which enhance patient care, enable real-time data analysis, and support personalized healthcare solutions.
North America accounted for the largest share in the medical devices market, driven by advanced healthcare infrastructure, high adoption of innovative medical technologies, strong R&D investments, and the presence of leading global medical device manufacturers.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A3050
sales@skyquestt.com
USA +1 351-333-4748